115 related articles for article (PubMed ID: 37308003)
1. Blastocystis sp. reduces the efficacy of 5-fluorouracil as a colorectal cancer chemotherapeutic treatment.
Kumarasamy V; Kuppusamy UR; Jayalakshmi P; Govind SK
Exp Parasitol; 2023 Aug; 251():108564. PubMed ID: 37308003
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer.
Refaat B; El-Shemi AG; Kensara OA; Mohamed AM; Idris S; Ahmad J; Khojah A
J Exp Clin Cancer Res; 2015 Jul; 34(1):71. PubMed ID: 26205949
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.
Kensara OA; El-Shemi AG; Mohamed AM; Refaat B; Idris S; Ahmad J
Drug Des Devel Ther; 2016; 10():2239-53. PubMed ID: 27468227
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
Ganguly K; Kulkarni AR; Aminabhavi TM
Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
[TBL] [Abstract][Full Text] [Related]
5. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin Liposomes Combined with 5-Fluorouracil Inhibits Angiogenesis and Tumor Growth of APC
Liu XM; Zhu WT; Jia ML; Li YT; Hong Y; Liu ZQ; Yan PK
Int J Nanomedicine; 2022; 17():5049-5061. PubMed ID: 36325149
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Mashtoub S
Scand J Gastroenterol; 2020 Jan; 55(1):47-54. PubMed ID: 31825688
[No Abstract] [Full Text] [Related]
8. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
[TBL] [Abstract][Full Text] [Related]
9. Paricalcitol Enhances the Chemopreventive Efficacy of 5-Fluorouracil on an Intermediate-Term Model of Azoxymethane-Induced Colorectal Tumors in Rats.
El-Shemi AG; Refaat B; Kensara OA; Mohamed AM; Idris S; Ahmad J
Cancer Prev Res (Phila); 2016 Jun; 9(6):491-501. PubMed ID: 27020656
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of vitamin D
Aslam A; Ahmad J; Baghdadi MA; Idris S; Almaimani R; Alsaegh A; Alhadrami M; Refaat B
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166040. PubMed ID: 33338596
[TBL] [Abstract][Full Text] [Related]
11. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
[TBL] [Abstract][Full Text] [Related]
13. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
14. A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment.
Huang CJ; Yang SH; Huang SM; Lin CM; Chien CC; Chen YC; Lee CL; Wu HH; Chang CC
J Transl Med; 2011 May; 9():82. PubMed ID: 21619678
[TBL] [Abstract][Full Text] [Related]
15. Current Perspectives on the Role of Nrf2 in 5-Fluorouracil Resistance in Colorectal Cancer.
Gong J; Xu H
Anticancer Agents Med Chem; 2021; 21(17):2297-2303. PubMed ID: 33511942
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
17. Use of a chemically induced-colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassay.
Yoshimi K; Hashimoto T; Niwa Y; Hata K; Serikawa T; Tanaka T; Kuramoto T
BMC Cancer; 2012 Oct; 12():448. PubMed ID: 23031214
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of colon carcinogenesis by Blastocystis sp.
Kumarasamy V; Kuppusamy UR; Jayalakshmi P; Samudi C; Ragavan ND; Kumar S
PLoS One; 2017; 12(8):e0183097. PubMed ID: 28859095
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
20. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
